Skip to main content

Table 2 Primers used to study promoter hypermethylation of different genes

From: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival

Gene

Name

Primer sequence

DAPK1

Unmethylated forward

5′-GGAGGATAGTTGGATTGAGTTAATGTT-3′

Unmethylated Reverse

5′-CAAATCCCTCCCAAACACCAA-3′

Methylated forward

5′-GGATAGTCGGATCGAGTTAACGTC-3′

Methylated Reverse

5′-CCCTCCCAAACGCCGA-3′

RIZ-1

Unmethylated forward

5′-TGGTGGTTATTGGGTGATGGT-3′

Unmethylated Reverse

5′-ACTATTTCACCAACCCCAAGA-3′

Methylated forward

5′-GTGGTGGTTATTGGGCGACGGC-3′

Methylated Reverse

5′-GCTATTTCGCCGACCCCGACG-3′

P16INK4A

Unmethylated forward

5′-TTATTAGAGGGTGGGGTGGATTGT-3′

Unmethylated Reverse

5′-CAACCCCAAACCACAACCATAA -3′

Methylated forward

5′-TTATTAGAGGGTGGGGCGGATCGC-3′

Methylated Reverse

5′-GACCCCGAACCGCGACCGTAA -3′

RASSF1A

Unmethylated forward

5′-GGGTTTTGCGAGAGCGCGT-3′

Unmethylated Reverse

5′-GCTAACAAACGCGAACCG-3′

Methylated forward

5′- GGTTTTGTGAGTGTGTTTAGT-3′

Methylated Reverse

5′-CACTAACACACAAACCAAACA-3′

SOCS1

Unmethylated forward

5′-TCGTTCGTACGTCGATTATC-3′

Unmethylated Reverse

5′-AAAAAAATACCCACGAACTCG-3′

Methylated forward

5′-TATTTTGTTTGTATGTTGATTATTG-3′

Methylated Reverse

5′-AAACTCAACACACAACCACTC-3′

p14ARFARF

Unmethylated forward

5'-TTTTGGTGTTAAAGGGTGGTGTAGT-3 ‘

Unmethylated Reverse

5'- CACAAAAACCCTCACTCACAACAA-3'

Methylated forward

5'-GTGTTAAAGGGCGGCGTAGC-3’

Methylated Reverse

5'- AAAACCCTCACTCGCGACGA-3'